Back
Aligos Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
ALGS
Aligos Therapeutics, Inc.
Last Price:
$7.00
Seasonality Move:
-25.49%
7 Day Trial
ALL ACCESS PASS
$
7
Aligos Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 50.8% based on the past 5 years of stock performance.
-
Aligos Therapeutics, Inc. has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Aligos Therapeutics, Inc. Stock Undervalued?The current Aligos Therapeutics, Inc. [ALGS] share price is $7.03. The Score for ALGS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Aligos Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 50.8% based on the past 5 years of stock performance.
Aligos Therapeutics, Inc. Stock Rating
Sell
27
Aligos Therapeutics, Inc. (ALGS)
is a Sell
Is Aligos Therapeutics, Inc. overpriced?
-
Aligos Therapeutics, Inc. has fallen lower in 5 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Aligos Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aligos.com
52-Week Data
52-Week High:
13.69
52-Week Low:
3.76
Prediction Charts
Market Cap:
43.7M
Price in USD:
7.03
Volume:
37.3K
Beta:
2.76
Technical Analysis
SMA50:
7.95
SMA100:
8.63
SMA200:
8.61
52-Wk Change:
-45.71%
Stock Predictions
-
Is Aligos Therapeutics, Inc. stock public?Yes, Aligos Therapeutics, Inc. is a publicly traded company.
-
What is the Aligos Therapeutics, Inc. stock quote today?The Aligos Therapeutics, Inc. stock price is 7.03 USD today.
-
How to buy Aligos Therapeutics, Inc. stock online?You can buy Aligos Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-18 | 6.59 | 6.80 | 7.07 | 6.59 |
| Feb-19 | 6.73 | 7.12 | 7.19 | 6.59 |
| Feb-20 | 7.12 | 6.80 | 7.13 | 6.77 |
| Feb-23 | 6.85 | 6.94 | 7.19 | 6.58 |
| Feb-24 | 7.00 | 7.09 | 7.25 | 6.85 |
| Feb-25 | 7.06 | 6.94 | 7.10 | 6.73 |
| Feb-26 | 6.99 | 7.50 | 7.50 | 6.91 |
| Feb-27 | 7.36 | 7.03 | 7.38 | 6.95 |
| Mar-2 | 6.88 | 6.97 | 7.08 | 6.31 |
| Mar-3 | 6.75 | 6.85 | 6.92 | 6.50 |
| Mar-4 | 6.75 | 6.86 | 7.17 | 6.73 |
| Mar-5 | 6.80 | 6.66 | 7.01 | 6.38 |
| Mar-6 | 6.40 | 6.98 | 7.37 | 6.37 |
| Mar-9 | 6.94 | 7.03 | 7.30 | 6.56 |
Aligos Therapeutics, Inc. Earnings
Aligos Therapeutics, Inc. Earnings Report: Per Share Aligos Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Aligos Therapeutics, Inc. Forecast Revenue Growth
Aligos Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.92 per share, and an increase next year of $0.49 per share.
* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.